Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sherif Suleiman"'
Autor:
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, Yashwanth Subbannayya, Sarah Suleiman, Mariela Vasileva-Slaveva, Angel Yordanov, Francesca Pentimalli, Antonio Giordano, Jean Calleja-Agius
Publikováno v:
Cells, Vol 12, Iss 10, p 1415 (2023)
The F-Box and WD Repeat Domain Containing 7 (FBXW7) protein has been shown to regulate cellular growth and act as a tumor suppressor. This protein, also known as FBW7, hCDC4, SEL10 or hAGO, is encoded by the gene FBXW7. It is a crucial component of t
Externí odkaz:
https://doaj.org/article/f71999e77c974696b379322328405bd7
Autor:
Sherif Suleiman, Riccardo Di Fiore, Analisse Cassar, Melissa Marie Formosa, Jean Calleja-Agius, Pierre Schembri-Wismayer
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 130, Iss , Pp 110549- (2020)
Current anti-cancer drugs can cause many undesirable side effects to patients. Thus, there is a constant need to develop alternative therapeutic drugs. Bioactive compounds derived from natural products including animals, plants and microorganisms are
Externí odkaz:
https://doaj.org/article/993bd69bf5df4db48ef817f8e6560a00
Autor:
Sherif Suleiman, Riccardo Di Fiore, Analisse Cassar, Melissa Marie Formosa, Pierre Schembri-Wismayer, Jean Calleja-Agius
Publikováno v:
Tumor Biology, Vol 42 (2020)
Acute myeloid leukemia is the most common form of acute leukemia in adults, constituting about 80% of cases. Although remarkable progress has been made in the therapeutic scenario for patients with acute myeloid leukemia, research and development of
Externí odkaz:
https://doaj.org/article/e601f453af054dc58b7c7dd0a69382e6
Endometrial carcinoma in patients under 40 years of age: insights from the Bulgarian Cancer Registry
Autor:
Angel Yordanov, Stoyan Kostov, Yavor Kornovski, Stanislav Slavchev, Yonka Ivanova, Jean Calleja-Agius, Riccardo Di Fiore, Sherif Suleiman, Andra Piciu, Ihsan Hasan, Mariela Vasileva-Slaveva
Publikováno v:
Ginekologia Polska. 94:275-282
Objectives: We aimed to investigate the overall survival (OS) of young women with endometrial cancer (EC) in Bulgaria and the impact of histological type on survival.
Material and methods: This is a population-wide retrospective study of patient
Material and methods: This is a population-wide retrospective study of patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f894571cbe9307961ae28b81fa561fb
https://doi.org/10.5603/gp.a2022.0106
https://doi.org/10.5603/gp.a2022.0106
Autor:
Riccardo Di Fiore, Mark Ward, Sherif Suleiman, Sureyya Ozcan, Maja Sabol, Jean Calleja-Agius, Petar Ozretić
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5040, p 5040 (2021)
Cancers, Vol 13, Iss 5040, p 5040 (2021)
Rare ovarian cancers (ROCs) are OCs with an annual incidence of fewer than 6 cases per 100,000 women. They affect women of all ages, but due to their low incidence and the potential clinical inexperience in management, there can be a delay in diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::819f135779ee30013a5377ad45bb1870
https://pubmed.ncbi.nlm.nih.gov/34680193
https://pubmed.ncbi.nlm.nih.gov/34680193
Autor:
Riccardo, Di Fiore, Sherif, Suleiman, Rosa, Drago-Ferrante, Ana, Felix, Sharon A, O'Toole, John J, O'Leary, Mark P, Ward, James, Beirne, Angel, Yordanov, Mariela, Vasileva-Slaveva, Yashwanth, Subbannayya, Francesca, Pentimalli, Antonio, Giordano, Jean, Calleja-Agius
Publikováno v:
International Journal of Molecular Sciences
Gynecological cancers (GCs) are currently among the major threats to female health. Moreover, there are different histologic subtypes of these cancers, which are defined as ‘rare’ due to an annual incidence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20314e49a7b21313d1cb84045009dbe4
https://pubmed.ncbi.nlm.nih.gov/34360598
https://pubmed.ncbi.nlm.nih.gov/34360598
Autor:
Ian Said-Huntingford, John J. O'Leary, Riccardo Di Fiore, Bridget Ellul, Duncan Ayers, James P Beirne, Mariela Vasileva-Slaveva, Maja Sabol, Antonio Giordano, Margarita Nikolova, Ana Félix, Sherif Suleiman, Sharon O'Toole, Jean Calleja-Agius, Petar Ozretić, Francesca Pentimalli, Mark Ward, Angel Yordanov, Stoyan Kostov
Publikováno v:
International Journal of Molecular Sciences
International journal of molecular sciences
International Journal of Molecular Sciences, Vol 22, Iss 6506, p 6506 (2021)
International journal of molecular sciences
International Journal of Molecular Sciences, Vol 22, Iss 6506, p 6506 (2021)
Choriocarcinoma (CC), a subtype of trophoblastic disease, is a rare and highly aggressive neoplasm. There are two main CC subtypes: gestational and non-gestational, (so called when it develops as a component of a germ cell tumor or is related to a so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165f4915d98d688f0e1cd91cf09ad9aa
http://europepmc.org/articles/PMC8235025
http://europepmc.org/articles/PMC8235025
Autor:
Sherif Suleiman, Sharon O'Toole, John J. O'Leary, C. Simon Herrington, Mark Ward, Maja Sabol, Jean Calleja-Agius, Petar Ozretić, Antonio Giordano, Riccardo Di Fiore, Ayse Elif Erson-Bensan, Neil T Conlon, Francesca Pentimalli, Nicholas Reed
Publikováno v:
Di Fiore, R, Suleiman, S, Pantimalli, F, O’Toole, S A, O'Leary, J J, Ward, M, Conlon, N T, Sabol, M, Ozretic, P, Erson-Bensan, A E, Reed, N, Giordano, N, Herrington, C S & Calleja-Agius, J 2021, ' Could MicroRNAs be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview ', Molecular Pharmacology . https://doi.org/10.3390/ijms22083822
International Journal of Molecular Sciences, Vol 22, Iss 3822, p 3822 (2021)
International Journal of Molecular Sciences
International journal of molecular sciences
International Journal of Molecular Sciences, Vol 22, Iss 3822, p 3822 (2021)
International Journal of Molecular Sciences
International journal of molecular sciences
Gynecological cancers pose an important public health issue, with a high incidence among women of all ages. Gynecological cancers such as malignant germ-cell tumors, sex-cord-stromal tumors, uterine sarcomas and carcinosarcomas, gestational trophobla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecce29fbd8ddbe7af65a04e180e5a4d
https://www.pure.ed.ac.uk/ws/files/204047053/Could_MicroRNAs_be_Useful_Tools_to_Improve_the_Diagnosis_and_Treatment_of_Rare_Gynecological_Cancers_A_Brief_Overview_final.pdf
https://www.pure.ed.ac.uk/ws/files/204047053/Could_MicroRNAs_be_Useful_Tools_to_Improve_the_Diagnosis_and_Treatment_of_Rare_Gynecological_Cancers_A_Brief_Overview_final.pdf
Autor:
Valerio Napolioni, David Faraggi, Miriam J Azzopardi, Neil T Conlon, Neville Calleja, Miriam Dalmas, Ilker Kahramanoglu, Bridget Ellul, Paul Kubelac, Sherif Suleiman, Mark R. Brincat, Sharon O'Toole, C. Simon Herrington, Ana Félix, Róbert Póka, Catalin Vlad, Jean Calleja-Agius, Antonio Giordano, Riccardo Di Fiore, Yves Muscat-Baron, Patriciu Achimaș-Cadariu, Olga Tzortzatou, Rachel A Micallef, Angel Yordanov, Charles Savona-Ventura, Vera Dimitrievska, Alex E. Felice, Nicholas Reed, Mariela Vasileva-Slaveva, Kristelle von Brockdorff, Maja Sabol
Publikováno v:
Cancers
Volume 13
Issue 3
Cancers, Vol 13, Iss 493, p 493 (2021)
Di Fiore, R D, Suleiman, S, Ellul, B, O’toole, S A, Savona-ventura, C, Felix, A, Napolioni, V, Conlon, N T, Erson-bensan, A E, Kahramanoglu, I, Azzopardi, M J, Dalmas, M, Calleja, N, Brincat, M R, Muscat-baron, Y, Sabol, M, Dimitrievska, V, Yordanov, A, Vasileva-slaveva, M, Von Brockdorff, K V, Micallef, R A, Kubelac, P, Achimas-cadariu, P, Vlad, C, Tzortzatou, O, Poka, R, Giordano, A, Felice, A, Reed, N, Herrington, C S, Faraggi, D & Calleja-agius, J 2021, ' GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors—Current Challenges and Future Directions ', Cancers, vol. 13, no. 3, pp. 493 . https://doi.org/10.3390/cancers13030493
Volume 13
Issue 3
Cancers, Vol 13, Iss 493, p 493 (2021)
Di Fiore, R D, Suleiman, S, Ellul, B, O’toole, S A, Savona-ventura, C, Felix, A, Napolioni, V, Conlon, N T, Erson-bensan, A E, Kahramanoglu, I, Azzopardi, M J, Dalmas, M, Calleja, N, Brincat, M R, Muscat-baron, Y, Sabol, M, Dimitrievska, V, Yordanov, A, Vasileva-slaveva, M, Von Brockdorff, K V, Micallef, R A, Kubelac, P, Achimas-cadariu, P, Vlad, C, Tzortzatou, O, Poka, R, Giordano, A, Felice, A, Reed, N, Herrington, C S, Faraggi, D & Calleja-agius, J 2021, ' GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors—Current Challenges and Future Directions ', Cancers, vol. 13, no. 3, pp. 493 . https://doi.org/10.3390/cancers13030493
More than 50% of all gynecologic tumors can be classified as rare (defined as an incidence of less than 6 per 100,000 women) and usually have a poor prognosis owing to delayed diagnosis and treatment. In contrast to almost all other common solid tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061177c23295152b135d8b070c932f22